November 01, 2014

   
img]

INFORMATION FOR CONTRIBUTORS

Established in 1956, The Canadian Journal of Psychiatry (The CJP) is the official journal of the Canadian Psychiatric Association (CPA). Publishing 12 issues a year, The CJP contains original, previously unpublished, peer-reviewed scientific articles related to all aspects of Canadian and international psychiatry.

Manuscript Types

The following describes the manuscript (MS) types published in The CJP, including requirements for each, such as word count (not including structured abstracts, acknowledgements, references, tables, and figures) and number of tables and figures. These restrictions are enforced to enable The CJP to publish as many papers in each issue as possible.

In Review
The Editor-in-Chief invites Guest Editors to take part in the In Review series. Unsolicited MSs are not accepted. This popular and highly cited series provides an updated and authoritative statement about an area of psychiatry. Papers define the issues, identify parameters, provide a brief history highlighting the main research findings and clinical applications, and identify remaining issues and the efforts made to address them. The Guest Editorial should be 700 to 1500 words. Papers must not exceed 3500 words, with a maximum combined total of 5 figures and tables.

Original Research
Papers must not exceed 3500 words, with a maximum of 5 figures and tables, combined.

Systematic Review
The CJP encourages submission of Systematic Reviews. Papers must adhere to the same word, table, and figure limits as Original Research articles. Authors should register reviews in a suitable registry, such as PROSPERO (http://www.crd.york.ac.uk/PROSPERO/index.asp). To ensure completeness of reporting, papers should use the PRISMA checklist and include a PRISMA flow sheet (see: http://www.prisma-statement.org) as a figure.

Perspectives
The CJP publishes brief articles covering emerging, contentious, or complex themes relevant to the journal’s mandate. Papers are not expected to provide a comprehensive coverage of existing literature and may instead adopt a specific perspective on a contemporary problem or issue. Papers must not exceed 2500 words and do not require an abstract. Papers are limited to 1 table or figure.

Brief Communications
Preliminary reports and secondary studies from previous publications may be accepted as Brief Communications. Papers must not exceed 1500 words, with a maximum of 3 figures and tables, combined. The CJP does not publish case reports.

Book Reviews
The Book Review Associate Editor invites authors to review books of interest to The CJP readers, including general psychiatry, specific areas of psychiatry and subspecialties, and other nonfiction works dealing with mental health. Tables and figures are not accepted. Direct quotes should include reference and page numbers.

Letters to the Editor
Letters must be related to The CJP-published articles; case reports are not accepted. Letters must not exceed 500 words. Tables and figures are not accepted. Once accepted, the Editorial Office will contact the corresponding author of the article in question to reply. The letter and reply will be published together.

MS Preparation

With minor exceptions, MS requirements are based on 3 sources:
• International Committee of Medical Journal Editors (ICMJE). Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals [Internet]. ICMJE. [updated 2013 Aug; cited 2013 Sep 6]. Available from: http://www.icmje.org/urm_main.html
• Council of Science Editors, Style Manual Committee. Scientific style and format: the CSE manual for authors, editors and publishers. 7th ed. Reston (VA): The Council; 2006.
• Barber K, editor. Canadian Oxford dictionary. 2nd ed. Don Mills (ON): Oxford University Press; 2004.

An MS Template and MS Checklist are available for authors to use as a guide. Authors are encouraged to visit http://www.TheCJP.ca to view published articles.

Arrange the MS according to the sections listed below.

1. Title Page
Limit authors in the byline to those who substantially contributed to the concept and design, data acquisition, analysis, and interpretation; drafted or critically revised the MS for important intellectual content; and approved the final version for publication. People who referred patients; assisted with data collection, statistical analysis, or writing of the MS; or supervised and provided general support should not be included as authors but thanked in the Acknowledgements.

While author names, degrees, and institutions are included in the metadata for Manuscript Central, it is also required on the MS itself to facilitate editing before layout. The CJP does a single-blind, peer-review process in which author information is available to reviewers, but reviewers are kept confidential.

2. Abstract, Clinical Implications and Limitations, Key Words, and Abbreviations
Abstracts must not be more than 250 words and should be structured under the following headings: Objective, Method, Results, and Conclusions. References are not acceptable in the Abstract. If applicable, the clinical trial or systematic review registration number should appear at the end of the Abstract (see Clinical Trial Registration below). The CJP translates the Abstract into French or English.

Provide 2 to 3 Clinical Implications and 2 to 3 Limitations of the study. These should be short, complete sentences (less than 20 words each) that do not repeat the Abstract Results or Conclusions, but rather put the results into context so readers can apply the information in their practice or research. Emphasize what is new and important about the research.

Include 3 to 10 key words or short phrases for indexing purposes. MeSH terms are preferred.

Prepare an alphabetical list of all nonstatistical abbreviations used in the MS. If an abbreviation is used only once, it should be spelt out and not abbreviated. If less than 3 abbreviations are used, an abbreviations list is not required and the abbreviations should be spelt out in the text on first use, with the abbreviation in parenthesis.

3. Body Text
Refer to the MS Types above for the maximum words, tables, and figures allowed for each.

After a short introductory section that clearly states the objective of, or the hypothesis tested by, the research, arrange the MS under the headings Method, Results, Discussion, and Conclusions. See the MS Template for what should be included in each section of the MS and use the MS Checklist to ensure all of the article requirements are met.

NOTE: MSs that are significantly above the word count limit or are missing multiple, important elements will be unsubmitted from consideration, delaying peer review, decision, and publication.

4. Acknowledgements
Each coauthor must complete and sign an Author Disclosure Form, which should be uploaded to Manuscript Central with the MS. The information provided on the forms should be included in this section. If no funding was received, this should be clearly stated.

Authors may thank people who were involved with specific content of the work but who do not qualify as authors.

If a personal communication is referenced in the MS (as a parenthetical statement, not in the reference list), the Acknowledgements section should include a statement that the person quoted gave permission for the information to be used. A copy of the email or letter granting permission should be sent to the Editorial Office for its records.

5. References
Accuracy of citations, exact spelling, accents, and punctuation of the original reference is the author’s responsibility.

The CJP follows a citation sequence referencing style with superscript numbers based on the Scientific Style and Format: The CSE Manual for Authors, Editors, and Publishers. Number references in the order of their first appearance in the text, using the same number when repeating the reference. Direct quotes should include the page number (for example4, p 3).

In the References, do not include personal communications, unpublished MSs, or MSs submitted but not yet accepted for publication. Note these parenthetically in the text as follows: (name, date, and personal communication) or (unpublished observation). Authors must provide the Editorial Office with a letter or email indicating that permission to publish the information was granted from the source of the personal communication or from the publisher. Accepted, but forthcoming MSs may be cited in the References: include the journal title (or book publisher and location) and tentative print date.

For reference manager software, use the style for the National Library of Medicine; otherwise, use the following style, noting the punctuation and capitalization.
• List the first 3 authors, followed by et al. Note punctuation conventions with author names (for example, Doe J, not Doe, J).
• Place book and article titles in sentence case, capitalizing only the first word, acronyms, and proper nouns.
• Use National Library of Medicine abbreviations but do not abbreviate journals that are not listed in the NLM catalog at http://www.hcbi.nlm.nih.gov/nlmcatalog/journals.
• Do not italicize titles.
• When citing journal articles, include the volume and the issue number and do not include a space after colons and semicolons.
• Separate page ranges with an en-dash and do not omit any digits of the closing page number.

6. Tables and Figures
Keep the number of tables and figures to a minimum, using them to present relevant numerical data. Short tables can often be incorporated more concisely in the text. Tables and figures should complement, not repeat, the text and should be understandable without reference to the text. Cite each table and figure in the text and number them consecutively in the order of their first citation in the text. Tables will be placed near these citations. Include a brief descriptive title. Give each column a short or abbreviated heading. Include units of measure. P values up to 3 decimal places should be used, not *, **, and ***. Explanatory matter, such as nonstatistical abbreviations not included in the abbreviations list, should be in the footnotes (using superscript, lower-case letters), not in the heading. If tables or figures from another published or unpublished source are used, authors must obtain permission and acknowledge the source in the footnote.

Large tables and figures (3 double-spaced MS pages) will not be accepted for print publication but may be made available online. Tables and figures will be printed in black and white, but will be available in colour online. Authors who require their tables and figures to be printed in colour will agree to cover the additional printing costs (Can$500).

Tables and figures will be edited to conform to The CJP style, so original files are preferred to image files.

Clinical Trial Registration


The International Committee of Medical Journal Editors defines a clinical trial as
any research project that prospectively assigns people to an intervention, with or without concurrent comparison or control groups, to study the cause-and-effect relationship between a health-related intervention and a health outcome. Health-related interventions are those used to modify a biomedical or health-related outcome; examples include drugs, surgical procedures, devices, behavioural treatments, dietary interventions, quality improvement interventions, and process-of-care changes. Health outcomes are any biomedical or health-related measures obtained in patients or participants, including pharmacokinetic measures and adverse events.p 11

To be considered for publication in The CJP, clinical trials must be registered at or before the onset of patient enrolment. The registry must meet several criteria, including: being accessible to the public at no charge; being open to all prospective registrants; being managed by a not-for-profit organization; having a mechanism to ensure the validity of the registration data; and being electronically searchable. Examples include http://clinicaltrials.gov and http://www.who.int/ictrp/network/primary/en/index.html. The registration name and number should be listed at the end of the Abstract.

While trial methodology must be registered, trial results need not be registered. Should the authors decide to register the results, they must be registered in the same registry as the initial methodology to be considered previously unpublished.

MS Submission and Processing


The CJP has a rapid-publication policy and uses ScholarOne Manuscripts (formerly Manuscript Central) as its online MS submission and peer-review processing system. The CJP does not accept MS submissions, revisions, or reviews by mail or email. Authors can go to http://mc.manuscriptcentral.com/cjp to log in or create an account to submit their articles. The website has helpful instructions, tutorials, and technical support to assist authors in uploading their MSs. Solicited MSs (for example, In Reviews and Book Reviews) are the only exception and should be emailed to CJP@cpa-apc.org.

Authors will be notified by email of successful receipt of their MSs and of the tracking numbers assigned to them. These numbers must be included in all correspondence. Authors are responsible for keeping their contact information up to date in ScholarOne Manuscripts. This includes email and mailing addresses as well as phone and fax numbers.

All MSs are reviewed to determine the originality, validity, and importance of content and conclusions. Authors may suggest potential peer reviewers for their MSs; however, The CJP is not obligated to follow the suggestion. Authors will be provided with anonymous peer reviewers’ comments to make necessary revisions, usually within 2 months, before MSs can be accepted for publication. The authors will be informed of the final decision of the Editor-in-Chief. All editorial decisions are final.

Revised MSs, including tables and figures, are accepted with the understanding that they will be edited for conciseness, clarity, and conformity with The CJP style. Copyedited MS and page proofs will be sent to the corresponding author for corrections, answers to queries, and approval.

Copyright

Authors must comply with international copyright laws and obtain all necessary rights and permissions to reprint material, including tables and figures, from secondary sources. A copy of such permission(s) must be included with the MS submission and a footnote included with the table or figure stating from whom permission was obtained.

The CJP requires all coauthors to transfer copyright of their MSs to the CPA so the author(s) and the CPA are protected from misuse of copyrighted material. A Copyright Transfer Form will be sent to the corresponding author when the MS has received final acceptance for publication. All coauthors are required to sign and return the form by email, fax, or mail to the Editorial Office. If the forms are not received from each coauthor, publication of the MS may be delayed.

Open Access Option

Until recently, only Canadian Psychiatric Association members/affiliates and journal subscribers could get instant access to The CJP online, otherwise, a 6-month embargo applies. Now, authors who would like to have their articles freely accessible to everybody immediately upon publication can pay Can$3000, with Canadian Psychiatric Association members/affiliates getting a 50% discount. Many agencies require open access of their funded research and provide funding for this reason. The fee is payable anytime after a manuscript has been accepted (it does not affect the editorial decision) and before the publication date by completing the Open Access form and emailing it to CJP@cpa-apc.org. Corresponding authors living in Canada must pay applicable GST/HST for their province or territory.

Permission to Redistribute


Written permission to redistribute material published in The CJP must include a completed Permission to Redistribute form emailed to CJP@cpa-apc.org.

Authors are granted permission to archive PDFs of the final printed versions of their articles in their institutions’ archive 6 months after publication

Reprints


Reprints are provided for a fee. An order form for reprints will be sent to the corresponding author before publication of the paper. The reprints will be mailed about 2 weeks after the article has been published.

Media Release


The CJP issues a media advisory as each issue arrives in readers’ mailboxes. Articles are embargoed until that time. Authors will be asked to fill out an Author Permission for Media Inquiries form to designate a spokesperson and permit the CPA to release that person’s telephone number and email address to the media, if requested.

Questions


For further information, contact The CJP Editorial Office at (613) 234-2815 ext 230 or CJP@cpa-apc.org. For technical support for ScholarOne Manuscripts, call (434) 817-2040 or clicking Get Help Now in the top right corner of the ScholarOne Manuscripts screen.

Next Issue

Current Issue

Past Issues

Subject and Author indices

Editorial Board

Advertising Information

Subscription Information

Instructions for Authors
Questions or comments about our site? Please contact us at cpanet@cpa-apc.org
The Canadian Psychiatric Association, Copyright 2001-2012